H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

H.R. 1492 is a federal bill in the 119th Congress. Before this bill, traditional chemical drugs could have their prices negotiated by Medicare after being on the market for 7 years, while complex biological drugs required 11 years. This bill changes the rule so that both types of drugs must be on the… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.